The University of Kansas Cancer Center

Institution (Facility)

Homepage ROR

Also Known As

The University of Kansas Cancer Center, The University of Kansas Comprehensive Cancer Center

3.3K

Publications

237K

Citations

202

Authors

651

Concepts

About

The University of Kansas Cancer Center is a facility institution in Kansas City, United States known for medicine, cell biology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	41	219	12.5K
2	Engineering	23	68	6.4K
3	Education	10	21	1.1K
4	Arts	2	3	103
5	Law	1	1	40

The University of Kansas Cancer Center

3.3K

Publications

237K

Citations

Page 1

	Year	Citations
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma Stephen J. Schuster, Michael Bishop, Constantine S. Tam, New England Journal of Medicine	2018	3.9K
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study Ghassan K. Abou‐Alfa, Vaibhav Sahai, Antoine Hollebecque, The Lancet Oncology Gastrointestinal OncologyMedicineHepatobiliary TumorBiliary CancerGastroenterology	2020	1.5K
Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer Takashi Kojima, Manish A. Shah, Kei Muro, Journal of Clinical Oncology	2020	1.1K
Adagrasib in Non–Small-Cell Lung Cancer Harboring a <i> KRAS <sup>G12C</sup> </i> Mutation Pasi A. Jänne, Gregory J. Riely, Shirish M. Gadgeel, New England Journal of Medicine	2022	886
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project Kenneth R. Carson, Andrew M. Evens, Elizabeth Richey, Blood	2009	866
Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study Sagar Lonial, Hans C. Lee, Ashraf Badros, The Lancet Oncology Hematological MalignancyMedicinePathologyBelantamab MafodotinCancer Treatment	2019	772
Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma Sapna P. Patel, Megan Othus, Yuanbin Chen, New England Journal of Medicine	2023	741
International patterns and trends in thyroid cancer incidence, 1973–2002 Briseis A. Kilfoy, Tongzhang Zheng, Theodore R. Holford, Cancer Causes & Control EpidemiologyCancer EpidemiologyMedicineThyroid DiseaseEpidemiology Of Cancer	2008	717
A microfluidic ExoSearch chip for multiplexed exosome detection towards blood-based ovarian cancer diagnosis Zheng Zhao, Yang Yang, Yong Zeng, Lab on a Chip EngineeringAnalytical MicrosystemsPathologyExtracellular MicrovesiclesOrgan-on-a-chip	2015	648
Recommended Guidelines for the Treatment of Cancer Treatment-Induced Diarrhea Al B. Benson, Jaffer A. Ajani, Robert B. Catalano, Journal of Clinical Oncology	2004	622

Page 1